Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR

BlackRock, Inc. reported a 10.10% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 27, 2026

BlackRock, Inc. reported a 10.10% stake in Arrowhead Pharmaceuticals, Inc., 14,232,545 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).

Stake
10.10%
Shares
14,232,545
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.10.10%14,232,545

Source

View original at SEC

Related